Sudden cardiac death in dilated cardiomyopathies

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue SUPPL. 2, 2009, Pages

  Hamilton, Robert M ^a   Azevedo, Eduardo R ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Non invasive risk assessment tests; Pediatrics; VT

Indexed keywords

AMIODARONE; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL SUCCINATE; SOTALOL; SPIRONOLACTONE;

AUTOSOMAL INHERITANCE; CARDIOVASCULAR RISK; CATHETER ABLATION; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DISEASE COURSE; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HEREDITY; HUMAN; MORBIDITY; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; SYSTOLIC DYSFUNCTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 68349092686     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02382.x     Document Type: Review

References (102)

1. Maron BJ, Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, et al. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006 113 : 1807 1816.
2. Richardson PJ. Assessment of myocardial damage in dilated cardiomyopathy. Eur Heart J 1996 17 : 489 490.
3. Bagger JP, Baandrup U, Rasmussen K, Moller M, Vesterlund T. Cardiomyopathy in western Denmark. Br Heart J 1984 52 : 327 331.
4. Codd MB, Sugrue DD, Gersh BJ, Melton LJ, 3rd. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 1989 80 : 564 572.
5. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994 331 : 1564 1575.
6. Gillum RF. Idiopathic dilated cardiomyopathy. Epidemiology 1994 5 : 383 385.
7. Miura K, Nakagawa H, Morikawa Y, Sasayama S, Matsumori A, Hasegawa K, Ohno Y, et al. Epidemiology of idiopathic cardiomyopathy in Japan: Results from a nationwide survey. Heart 2002 87 : 126 130.
8. Williams DG, Olsen EG. Prevalence of overt dilated cardiomyopathy in two regions of England. Br Heart J 1985 54 : 153 155.
9. Arola A, Jokinen E, Ruuskanen O, Saraste M, Pesonen E, Kuusela AL, Tikanoja T, et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol 1997 146 : 385 393.
10. Gagliardi MG. Dilated cardiomyopathy in children. Acta Paediatr Suppl 2006 95 : 14 16.
11. Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003 348 : 1647 1655.
12. Schmaltz AA. Dilated cardiomyopathy in childhood. Z Kardiol 2001 90 : 263 268.
13. Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006 296 : 1867 1876.
14. Grimm W, Maisch B. Sudden cardiac death in dilated cardiomyopathy - therapeutic options. Herz 2002 27 : 750 759.
15. Di Filippo S, Bozio A, Normand J, Andre M, Sassolas F, Jocteur-Monrozier D, Boissel JP, et al. Idiopathic dilated cardiomyopathies in children. Development and prognostic factors. Arch Mal Coeur Vaiss 1991 84 : 721 726.
16. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000 342 : 1077 1084.
17. Keeling PJ, McKenna WJ. Clinical genetics of dilated cardiomyopathy. Herz 1994 19 : 91 96.
18. Arad M, Lahat H, Freimark D. Genetic ideology of dilated cardiomyopathy. Isr Med Assoc J 2005 7 : 392 396.
19. Mestroni L, Rocco C, Gregori D, Sinagra G, Di Lenarda A, Miocic S, Vatta M, et al. Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Col Cardiol 1999 34 : 181 190.
20. Sinagra G, Di Lenarda A, Brodsky GL, Taylor MR, Muntoni F, Pinamonti B, Carniel E, et al. Current perspective new insights into the molecular basis of familial dilated cardiomyopathy. Ital Heart J 2001 2 : 280 286.
21. Cox GF, Sleeper LA, Lowe AM, Towbin JA, Colan SD, Orav EJ, Lurie PR, et al. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics 2006 118 : 1519 1531.
22. Ciszewski A, Bilinska ZT, Lubiszewska B, Poplawska W, Michalak E, Walczak F, Ruzyllo W. Dilated cardiomyopathy in children and adolescents. Diagnostic problems, clinical course and prognosis. Kardiol Pol 1991 35 : 354 359.
23. Rao PS, Najjar HN. Congestive cardiomyopathy due to chronic tachycardia: Resolution of cardiomyopathy with antiarrhythmic drugs. Int J Cardiol 1987 17 : 216 220.
24. Manz M, Wagner WL, Grube E, Luderitz B. Current concepts in the treatment of cardiac arrhythmias. J Cardiovasc Pharmacol 1986 8 (Suppl 2 S124 130.
25. Neri R, Mestroni L, Salvi A, Camerini F. Arrhythmias in dilated cardiomyopathy. Postgrad Med J 1986 62 : 593 597.
26. Unverferth DV, Magorien RD, Moeschberger ML, Baker PB, Fetters JK, Leier CV. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 1984 54 : 147 152.
27. Scrutinio D, Lagioia R, Ricci A, Clemente M, Boni L, Rizzon P. Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring. Eur Heart J 1994 15 : 1089 1095.
28. Bachinsky WB, Linzer M, Weld L, Estes NA, 3rd. Usefulness of clinical characteristics in predicting the outcome of electrophysiologic studies in unexplained syncope. Am J Cardiol 1992 69 : 1044 1049.
29. Lacroix D, Dubuc M, Kus T, Savard P, Shenasa M, Nadeau R. Evaluation of arrhythmic causes of syncope: Correlation between Holter monitoring, electrophysiologic testing, and body surface potential mapping. Am Heart J 1991 122 : 1346 1354.
30. Middlekauff HR, Stevenson WG, Saxon LA. Prognosis after syncope: Impact of left ventricular function. Am Heart J 1993 125 : 121 127.
31. Middlekauff HR, Stevenson WG, Stevenson LW, Saxon LA, et al. Syncope in advanced heart failure: High risk of sudden death regardless of origin of syncope. J Am Coll Cardiol 1993 21 : 110 116.
32. Grimm W, Hoffmann J, Menz V, Muller HH, Maisch B. Prediction of major arrhythmic events and sudden cardiac death in dilated cardiomyopathy. The Marburg Cardiomyopathy Study design and description of baseline clinical characteristics. Herz 2000 25 : 189 199.
33. Holmes J, Kubo SH, Cody RJ, Kligfield P. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: Prediction of mortality by ambulatory electrocardiography. Am J Cardiol 1985 55 : 146 151.
34. Chetty S, Mitha AS. Arrhythmias in idiopathic dilated cardiomyopathy. A preliminary study. S Afr Med J 1990 77 : 190 193.
35. Zecchin M, Di Lenarda A, Gregori D, Moretti M, Driussi M, Aleksova A, Chersevani D, et al. Prognostic role of non-sustained ventricular tachycardia in a large cohort of patients with idiopathic dilated cardiomyopathy. Ital Heart J 2005 6 : 721 727.
36. Morgera T, Di Lenarda A, Sabbadini G, Rakar S, Carniel E, Driussi M, Sinagra G. Idiopathic dilated cardiomyopathy: Prognostic significance of electrocardiographic and electrophysiologic findings in the nineties. Ital Heart J 2004 5 : 593 603.
37. Amiya E, Tanabe K, Ikari Y, Nakajima Y, Hara K. Prolonged QRS duration and severity of mitral regurgitation are unfavorable prognostic markers of heart failure in patients with nonischemic dilated cardiomyopathy. Circ J 2006 70 : 57 62.
38. Karaoguz R, Maydanozcu S, Altun T, Guldal M, Akyurek O, Erol C. Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy: Long term follow-up. Int Heart J 2006 47 : 763 773.
39. Milner PG, Dimarco JP, Lerman BB. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol 1988 11 : 562 568.
40. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006 48 : e247 346.
41. Friedman RA, Moak JP, Garson A, Jr. Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol 1991 18 : 152 156.
42. Muller G, Ulmer HE, Hagel KJ, Wolf D. Cardiac dysrhythmias in children with idiopathic dilated or hypertrophic cardiomyopathy. Pediatr Cardiol 1995 16 : 56 60.
43. Azevedo VM, Santos MA, Albanesi Filho FM, Castier MB, Tura BR, Amino JG. Outcome factors of idiopathic dilated cardiomyopathy in children - a long-term follow-up review. Cardiol Young 2007 17 : 175 184.
44. Steinberg JS, Berbari EJ. The signal-averaged electrocardiogram: Update on clinical applications. J Cardiovasc Electrophysiol 1996 7 : 972 988.
45. Cook JR, Flack JE, Gregory CA, Deaton DW, Rousou JA, Engelman RM. Influence of the preoperative signal-averaged electrocardiogram on left ventricular function after coronary artery bypass graft surgery in patients with left ventricular dysfunction. The CABG Patch Trial. Am J Cardiol 1998 82 : 285 289.
46. Steinberg JS, Hochman JS, Morgan CD, Dorian P, Naylor CD, Theroux P, Topol EJ, et al. Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late assessment of thrombolytic efficacy. Circulation 1994 90 : 746 752.
47. Turitto G, Fontaine JM, Ursell S, Caref EB, Bekheit S, el-Sherif N. Risk stratification and management of patients with organic heart disease and nonsustained ventricular tachycardia: Role of programmed stimulation, left ventricular ejection fraction, and the signal-averaged electrocardiogram. Am J Med 1990 88 : 35N 41N.
48. Mancini DM, Wong KL, Simson MB. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation 1993 87 : 1083 1092.
49. Turitto G, Ahuja RK, Bekheit S, Caref EB, Ibrahim B, el-Sherif N. Incidence and prediction of induced ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 1994 73 : 770 773.
50. Spencer CT, Bryant RM, Day J, Gonzalez IL, Colan SD, Thompson WR, Berthy J, et al. Cardiac and clinical phenotype in Barth syndrome. Pediatrics 2006 118 : e337 e346.
51. Spencer CT, Byrne BJ, Gewitz MH, Wechsler SB, Kao AC, Gerstenfeld EP, Merliss AD, et al. Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome. Pediatr Cardiol 2005 26 : 632 637.
52. Daubeney PE, Nugent AW, Chondros P, Carlin JB, Colan SD, Cheung M, Davis AM, et al. Clinical features and outcomes of childhood dilated cardiomyopathy: Results from a national population-based study. Circulation 2006 114 : 2671 2678.
53. Yotsukura M, Ishizuka T, Shimada T, Ishikawa K. Late potentials in progressive muscular dystrophy of the Duchenne type. Am Heart J 1991 121 : 1137 1142.
54. Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, Curtis AB, Kaufman ES, et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 2006 47 : 456 463.
55. Hohnloser SH, Klingenheben T, Bloomfield D, Dabbous O, Cohen RJ. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: Results from a prospective observational study. J Am Coll Cardiol 2003 41 : 2220 2224.
56. Sakabe K, Ikeda T, Sakata T, Kawase A, Kumagai K, Tezuka N, Takami M, et al. Comparison of T-wave alternans and QT interval dispersion to predict ventricular tachyarrhythmia in patients with dilated cardiomyopathy and without antiarrhythmic drugs: A prospective study. Jpn Heart J 2001 42 : 451 457. (Pubitemid 33040835)
57. Sakabe K, Ikeda T, Sakata T, Kawase A, Kumagai K, Tezuka N, Takami M, et al. Predicting the recurrence of ventricular tachyarrhythmias from T-wave alternans assessed on antiarrhythmic pharmacotherapy: A prospective study in patients with dilated cardiomyopathy. Ann Noninvasive Electrocardiol 2001 6 : 203 208. (Pubitemid 32706301)
58. Grimm W, Christ M, Bach J, Muller HH, Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: Results of the Marburg Cardiomyopathy Study. Circulation 2003 108 : 2883 2891.
59. Cheung MM, Davis AM, Cohen RJ, Wilkinson JL. T wave alternans threshold in normal children. J Cardiovasc Electrophysiol 2001 12 : 424 427.
60. Alexander ME, Cecchin F, Huang KP, Berul CI. Microvolt T-wave alternans with exercise in pediatrics and congenital heart disease: Limitations and predictive value. Pacing Clin Electrophysiol 2006 29 : 733 741.
61. Rashba EJ, Estes NA, Wang P, Schaechter A, Howard A, Zareba W, Couderc JP, et al. Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: Results from the DEFINITE trial. Heart Rhythm 2006 3 : 281 286.
62. Ohuchi H, Takasugi H, Ohashi H, Okada Y, Yamada O, Ono Y, Yagihara T, et al. Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation 2003 108 : 2368 2376.
63. Karakurt C, Aytemir K, Karademir S, Sungur M, Oguz D, Ocal B, Senocak F. Prognostic value of heart rate turbulence and heart rate variability in children with dilated cardiomyopathy. Acta Cardiol 2007 62 : 31 37.
64. Cuoco FA, Singh SN. Nonsustained ventricular tachycardia in dilated cardiomyopathy. Curr Cardiol Rep 2005 7 : 368 375.
65. Becker R, Haass M, Ick D, Krueger C, Bauer A, Senges-Becker JC, Voss F, et al. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy. Basic Res Cardiol 2003 98 : 259 266.
66. Merino JL. Mechanisms underlying ventricular arrhythmias in idiopathic dilated cardiomyopathy: Implications for management. Am J Cardiovasc Drugs 2001 1 : 105 118.
67. Kadish A, Schmaltz S, Calkins H, Morady F. Management of nonsustained ventricular tachycardia guided by electrophysiological testing. Pacing Clin Electrophysiol 1993 16 : 1037 1050.
68. Liem LB, Swerdlow CD. Value of electropharmacologic testing in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmias. Am J Cardiol 1988 62 : 611 616.
69. Poll DS, Marchlinski FE, Buxton AE, Josephson ME. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 1986 58 : 992 997.
70. Rae AP, Spielman SR, Kutalek SP, Kay HR, Horowitz LN. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy. Am J Cardiol 1987 59 : 291 295.
71. Constantin L, Martins JB, Kienzle MG, Brownstein SL, McCue ML, Hopson RC. Induced sustained ventricular tachycardia in nonischemic dilated cardiomyopathy: Dependence on clinical presentation and response to antiarrhythmic agents. Pacing Clin Electrophysiol 1989 12 : 776 783.
72. Neri R, Mestroni L, Salvi A, Pandullo C, Camerini F. Ventricular arrhythmias in dilated cardiomyopathy: Efficacy of amiodarone. Am Heart J 1987 113 : 707 715.
73. Stevenson WG, Weiss J, Stevenson LW, Tillisch JH. Facilitation of ventricular tachycardia initiation by procainamide during programmed ventricular stimulation in patients with heart failure. J Electrocardiol 1990 23 : 77 83.
74. Zrenner B, Koller B, Rudolph W. Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs? Herz 1990 15 : 90 102.
75. Ma JS, Kim BJ, Cho JG. Verapamil responsive incessant ventricular tachycardia resulting in severe ventricular dysfunction in a young child: Successful management with oral verapamil. Heart 1997 77 : 286 287.
76. Naumov VG, Khodzhakuliev BG, Belenkov Iu N. Permanent forms of tachyarrhythmia as the possible cause of the development of the dilated cardiomyopathy syndrome. Ter Arkh 1991 63 : 22 25.
77. Poll DS, Marchlinski FE, Buxton AE, Doherty JU, Waxman HL, Josephson ME. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: Electrophysiologic testing and lack of response to antiarrhythmic drug therapy. Circulation 1984 70 : 451 456.
78. Zehender M, Faber T, Furtwangler A, Hohnloser S, Meinertz T, Just H. Risk stratification and long-term therapy with amiodarone in patients with idiopathic dilated cardiomyopathy. Z Kardiol 1992 81 : 704 709.
79. Moak JP, Smith RT, Garson A, Jr. Newer antiarrhythmic drugs in children. Am Heart J 1987 113 : 179 185.
80. Silvetti MS, Drago F, Bevilacqua M, Ragonese P. Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy. Ital Heart J 2001 2 : 231 236.
81. Kottkamp H, Hindricks G, Chen X, Brunn J, Willems S, Haverkamp W, Block M, et al. Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy. Circulation 1995 92 : 1159 1168.
82. Blanck Z, Akhtar M. Ventricular tachycardia due to sustained bundle branch reentry: Diagnostic and therapeutic considerations. Clin Cardiol 1993 16 : 619 622.
83. Blanck Z, Dhala A, Deshpande S, Sra J, Jazayeri M, Akhtar M. Bundle branch reentrant ventricular tachycardia: Cumulative experience in 48 patients. J Cardiovasc Electrophysiol 1993 4 : 253 262.
84. Tezcan UK, Diker E, Ozdemir M, Heper G, Cehreli S, Goksel S. Radiofrequency catheter ablation treatment of a child with dilated cardiomyopathy secondary to chronic ectopic atrial tachycardia. Turk J Pediatr 1997 39 : 421 427.
85. Grimm W, Alter P, Maisch B. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT. Herz 2004 29 : 348 352.
86. Cleland JG, Freemantle N, Kaye G, Nasir M, Velavan P, Lalukota K, Mudawi T, et al. Clinical trials update from the American Heart Association meeting: Omega-3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, ORBIT and PAD and DEFINITE. Eur J Heart Fail 2004 6 : 109 115.
87. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 : 225 237.
88. Apitz C, Gass M, Dornberger V, Kuehlkamp V, Hofbeck M. The use of implantable cardioverter-defibrillators (ICD) in children and adolescents. Klin Padiatr 2006 218 : 270 275. (Pubitemid 44449001)
89. Caso P, Cioppa C, Musto B, De Leva F, Vitale D, Calabro R. Clinical aspects of dilated cardiomyopathy in pediatric age. Cardiologia 1990 35 : 839 844.
90. Akagi T, Benson LN, Lightfoot NE, Chin K, Wilson G, Freedom RM. Natural history of dilated cardiomyopathy in children. Am Heart J 1991 121 : 1502 1506.
91. Griffin ML, Hernandez A, Martin TC, Goldring D, Bolman RM, Spray TL, Strauss AW. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol 1988 11 : 139 144.
92. Lewis AB, Chabot M. Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol 1991 68 : 365 369.
93. Taliercio CP, Seward JB, Driscoll DJ, Fisher LD, Gersh BJ, Tajik AJ. Idiopathic dilated cardiomyopathy in the young: Clinical profile and natural history. J Am Coll Cardiol 1985 6 : 1126 1131.
94. Arola A, Tuominen J, Ruuskanen O, Jokinen E. Idiopathic dilated cardiomyopathy in children: Prognostic indicators and outcome. Pediatrics 1998 101 : 369 376. (Pubitemid 28136408)
95. Ciszewski A, Bilinska ZT, Lubiszewska B, Ksiezycka E, Poplawska W, Michalak E, Walczak E, et al. Dilated cardiomyopathy in children: Clinical course and prognosis. Pediatr Cardiol 1994 15 : 121 126.
96. Burch M, Siddiqi SA, Celermajer DS, Scott C, Bull C, Deanfield JE. Dilated cardiomyopathy in children: Determinants of outcome. Br Heart J 1994 72 : 246 250.
97. Matitiau A, Perez-Atayde A, Sanders SP, Sluysmans T, Parness IA, Spevak PJ, Colan SD. Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation 1994 90 : 1310 1318.
98. Weng KP, Lin CC, Huang SH, Hsieh KS. Idiopathic dilated cardiomyopathy in children: A single medical center's experience. J Chin Med Assoc 2005 68 : 368 372.
99. Bostan OM, Cil E. Dilated cardiomyopathy in childhood: Prognostic features and outcome. Acta Cardiol 2006 61 : 169 174.
100. Azevedo VM, Albanesi Filho FM, Santos MA, Castier MB, Tura BR. How can the echocardiogram be useful for predicting death in children with idiopathic dilated cardiomyopathy? Arq Bras Cardiol 2004 82 : 505 514.
101. Kothari SS, Dhopeshwarkar RA, Saxena A, Juneja R. Dilated cardiomyopathy in Indian children. Indian Heart J 2003 55 : 147 151.
102. Nogueira G, Pinto FF, Paixao A, Kaku S. Idiopathic dilated cardiomyopathy in children: Clinical profile and prognostic determinants. Rev Port Cardiol 2000 19 : 191 200.